Lee Xiong
Family · Sacramento, CANPI 1407589575
Payments from drug & device makers
Across 136 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$411
- Novo Nordisk$367
- AstraZeneca$309
- AbbVie$301
- GSK$256
- Lilly USA, LLC$223
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,932100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 30 | $411 |
| Novo Nordisk | 24 | $367 |
| AstraZeneca | 7 | $309 |
| AbbVie | 8 | $301 |
| GSK | 8 | $256 |
| Lilly USA, LLC | 10 | $223 |
| Hologic Sales And Service, LLC | 5 | $119 |
| Bayer | 4 | $104 |
| Merck | 4 | $85 |
| Gilead | 3 | $85 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $78 |
| Exact Sciences | 3 | $65 |
| Sanofi Pasteur Inc. | 3 | $64 |
| Novartis | 3 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $58 |
| Boehringer Ingelheim | 3 | $55 |
| Phadia US Inc. | 2 | $42 |
| Organon | 2 | $40 |
| Cranial Technologies, Inc | 2 | $29 |
| Biomarin Pharmaceutical Inc. | 1 | $25 |
| Seqirus USA Inc | 1 | $22 |
| Qiagen, LLC | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Amgen | 1 | $20 |
| Intra-sana Laboratories | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,932 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $788 |
| Gabapentin | 20 | $270 |
| Losartan Potassium | 31 | $197 |
| Ibuprofen | 29 | $128 |
| Amlodipine Besylate | 19 | $115 |
| Atorvastatin Calcium | 18 | $93 |
| Triamcinolone Acetonide | 15 | $80 |
| Cyclobenzaprine Hcl | 11 | $78 |
| Naproxen | 15 | $77 |
| Lisinopril | 13 | $55 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $52 |
| Furosemide | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other family in Sacramento
- Kim SchaferSacramento$288K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.